Episode
FuelCell Stock: Backlog Tripled, Margin Collapsed - We Say AVOID (FCEL Q3 FY2026)
- Published
- Sep 3, 2026
- Duration seconds
- 910
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/charged-alpha-stock-encyclopedia-7819792/episodes/fuelcell-stock-backlog-tripled-margin-collapsed-we-say-avoid-fcel-q3-fy2026/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/charged-alpha-stock-encyclopedia-7819792/fuelcell-stock-backlog-tripled-margin-collapsed-we-say-avoid-fcel-q3-fy2026.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
FuelCell Energy (FCEL) Q3 FY2026 — The stock fell 15.7% on the print, from $17.08 to $14.40, on 1.9x average volume. FuelCell Energy tripled its order book to $3.65bn and signed its first data-centre power agreement - and the stock lost about a sixth of its value in a single session. The reason is four lines into the cost statement: product revenue of $18.0m against product cost of revenues of $37.1m, a product gross margin of -106.1%. Note 7 of the 10-Q explains it - a $17.0m charge, $4.0m writing inventory to net realisable value and $13.0m for losses on firm purchase commitments, booked because contractual pricing under the Fit Energy agreement sits below what it costs to manufacture. That charge covers Phase 0 alone: 30 MW of a 380 MW agreement. Strip it out and the product margin is -11.7%, against -11.9% a year ago. Meanwhile $2.35bn of the new backlog is 'Awarded Capacity' the customer may take at its sole option, and FuelCell handed that customer warrants over 12,000,000 shares with a $141.6m grant-date fair value that will come back out as a reduction of revenue. Our call is AVOID, conviction 4/5, fair value $8.30. THE CALL: AVOID (4/5, HIGH) — base-case value ~$8.3 vs ~$14.4 today. KEY METRICS: - Revenue $33.0m, down 29% YoY and about 15% below the $38.8m consensus - Loss per share $(0.64) against a $(0.41) bar - roughly 56% wider than expected - Gross loss $(24.5)m vs $(5.1)m - gross margin -74.2% against -11.0% a year ago - Product revenue $18.0m against product cost of revenues $37.1m: product margin -106.1% - Note 7 charge $17.0m = $4.0m inventory NRV + $13.0m losses on firm purchase commitments - Ex-charge product gross margin -11.7%, versus -11.9% a year earlier - no improvement - 14th consecutive quarter without a gross profit; the last was the quarter…